Search

everythinglearnresearchcommunity

for

Search:↓

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Better hair loss models needed for research.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

People with a family history of hair loss are more likely to experience it, and the severity of hair loss is linked to insulin resistance. The connection between early hair loss and oxidative stress needs more investigation.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

FAGA shows varied hair thickness, while TE has more empty follicles.

Men with androgenetic alopecia may have higher triglycerides, suggesting a link to lipid metabolism.

Many women with PCOS have hair loss, linked to age, hirsutism, sleep issues, and smoking.

EH-MSCs may help treat hair loss by reducing inflammation.

Sesamin may help treat hair loss by affecting specific cell pathways.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

Liver disease is linked to hair loss, especially in women and those with unhealthy lifestyles.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

Lifestyle changes can significantly improve hair loss in overweight women with PCOS.

Higher testosterone and DHEA-S levels may be linked to male pattern baldness.

Higher fasting insulin levels increase the risk of androgenetic alopecia.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

Reduced alpha smooth muscle actin may cause hair loss in androgenetic alopecia.

Stem cell therapy shows promise for treating hair loss in androgenetic alopecia.

Mesenchymal stem cell-derived exosomes significantly increase hair density and thickness in androgenic alopecia patients.

Combining PRP therapy with minoxidil is the most effective treatment for hair loss in men.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Current treatments for androgenetic alopecia manage symptoms but don't cure it, and it affects social and psychological well-being.

Excess androgens may cause PCOS, not just be a symptom.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.